CJC 1295 and Ipamorelin dosage: benefits, mechanisms, and research applications The combination of CJC-1295, a growth hormone-releasing hormone (GHRH) analogue, and Ipamorelin, a selective ghrelin receptor agonist, has become a focal point in peptide research. By synergistically stimulating the pituitary gland to release endogenous growth hormone (GH), this duo offers
